Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

Macleods Pharmaceuticals Limited Issues Voluntary Nationwide Consumer Level Recall of One Lot (BLM 715A) of Losartan Potassium/Hydrochlorothiazide Combination Tablets 100mg/25mg Due to detection of NDEA (N-Nitrosodiethylamine) Impurity


Macleods Pharmaceuticals Limited is voluntarily recalling one lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer level due to the detection of trace amounts of an unexpected impurity (NDEA) found in finished product manufactured with active pharmaceutical ingredient made by Hetero Labs Limited. (US Food Recalls) More More

Similar stories

Recon: Merck to Buy Peloton for $1.1B to Boost Cancer Pipeline - Regulatory Focus

Recon: Merck to Buy Peloton for $1.1B to Boost Cancer Pipeline  Regulatory Focus

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Merck agrees $1bn deal to buy biopharmaceutical ...

Posted on 21 May 2019 | 2:00 am | Google News

Detection of Impurity Prompts Company to Recall 1 Lot of Combination Tablets - Pharmacy Times

Detection of Impurity Prompts Company to Recall 1 Lot of Combination Tablets  Pharmacy Times

Macleods Pharmaceuticals Limited has voluntarily recalled 1 lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer ...

Posted on 22 February 2019 | 3:00 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info